File(s) under permanent embargo
Was the Myriad decision a 'surgical strike' on isolated DNA patents, or does it have wider impacts?
journal contributionposted on 2023-05-21, 00:20 authored by Aboy, M, Crespo, C, Liddell, K, Johnathon LiddicoatJohnathon Liddicoat, Jordan, M
Five years later, what are the wider impacts of the US Supreme Court's Myriad decision on subject-matter eligibility and patent prosecution for nature-based products beyond isolated DNA?
Publication titleNature Biotechnology
Department/SchoolFaculty of Law
PublisherNature Publishing Group
Place of publication345 Park Ave South, New York, USA, Ny, 10010-1707
Rights statementCopyright © 2018, Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.